Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis

被引:47
作者
Brunner, TB
Merkel, S
Grabenbauer, GG
Meyer, T
Baum, U
Papadopoulos, T
Sauer, R
Hohenberger, W
机构
[1] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Dept Diagnost Radiol, D-91054 Erlangen, Germany
[4] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 62卷 / 04期
关键词
conformal radiotherapy; lymphatic metastasis; pancreatic carcinoma;
D O I
10.1016/j.ijrobp.2004.12.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: In chemoradiation for pancreatic carcinoma three-dimensional target volume definitions could maximize tolerability and therapeutic effect at the same time because toxicity correlates with treatment volume. We aimed to define guidelines for elective treatment of nodal areas based on pathologic nodal involvement to optimize treatment volume for this tumor. Methods and Materials: Pathologic patterns of regional nodal spread in 175 patients who underwent primary pancreatoduodenectomy with >= 10 assessed nodes and literature data on para-aortic spread were the base of the definition of the target volume. Significant correlations between spread to lymphatic areas and tumor characteristics were determined using Fisher's exact test. Computed tomography scans and a Pinnacle(3) (Philips, Best, The Netherlands) system were used for treatment planning. Results: Among 175 resected tumors without pretreatment, 76% had regional nodal metastasis and 22% had spread to distant nodes. High-risk lymphatic areas were identified and selected for elective treatment. A standardized planning procedure was derived and tested under treatment conditions. Conclusions: Histopathologic data allowed us to develop recommendations for standardized treatment planning for ductal carcinoma of the pancreatic head. These are proposed for quality assurance in multicenter studies and routine use. (c) 2005 Elsevier Inc.
引用
收藏
页码:1021 / 1029
页数:9
相关论文
共 38 条
  • [1] Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma
    Ando, N
    Nakao, A
    Nomoto, S
    Takeda, S
    Kaneko, T
    Kurokawa, T
    Nonami, T
    Takagi, H
    [J]. PANCREAS, 1997, 15 (04) : 374 - 378
  • [2] Bai YR, 2003, WORLD J GASTROENTERO, V9, P2561
  • [3] Benassai G, 2000, J SURG ONCOL, V73, P212
  • [4] Berger AC, 2004, AM SURGEON, V70, P235
  • [5] Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Brunner, TB
    Grabenbauer, GG
    Klein, P
    Baum, U
    Papadopoulos, T
    Bautz, W
    Hohenberger, W
    Sauer, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01): : 144 - 153
  • [6] Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer
    Bussels, B
    Goethals, L
    Feron, M
    Bielen, D
    Dymarkowski, S
    Suetens, P
    Haustermans, K
    [J]. RADIOTHERAPY AND ONCOLOGY, 2003, 68 (01) : 69 - 74
  • [7] Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index
    Crane, CH
    Wolff, RA
    Abbruzzese, JL
    Evans, DB
    Milas, L
    Mason, K
    Charnsangavej, C
    Pisters, PWT
    Lee, JE
    Lenzi, R
    Lahoti, S
    Vauthey, JN
    Janjan, NA
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (03) : 25 - 33
  • [8] AN ANATOMIC STUDY OF THE PERIPANCREATIC LYMPHATICS
    DEKI, H
    SATO, T
    [J]. SURGICAL AND RADIOLOGIC ANATOMY, 1988, 10 (02) : 121 - 135
  • [9] GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO
  • [10] 2-6